Purchase Order 75F40124P00280
Award Date
7/9/24
Potential Completion Date
8/19/24
Potential Value
$92K
Federal Agency
Food and Drug Administration
Awardee
Discovery Life Sciences, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Discovery Life Sciences, LLC, a small disadvantaged business, on August 2, 2022. The contract has a ceiling value of $48,945.00 and a completion date of November 1, 2022. The contract is for the procurement of primary human hepatocytes and media, as requested in the FDA's Sources Sought Notice FDA-SSN-1252684. Discovery Life Sciences has over a decade of experience supporting federal agencies'...
This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bioivt, LLC for the purchase of cryopreserved hepatocytes. The contract has a ceiling value of $16,179.20 and a completion date of August 16, 2024. Bioivt, LLC is a leading global provider of high-quality biological specimens and value-added services, with experience delivering similar products to federal agencies including the Defense Health Agency, Army Medical Command, National Institutes of Health,...
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
This is a $107,439.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Discovery Life Sciences, LLC, a small disadvantaged business, for the provision of human peripheral blood mononuclear cells (PBMC). The award has no set-aside designation and is scheduled for completion by September 30, 2022. Discovery Life Sciences, with over a decade of experience supporting federal research initiatives, will...
The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...
The Department of Health and Human Services' Food and Drug Administration awarded a firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for an INCUCYTE S3 LIVE-CELL ANALYSIS SYSTEM or equivalent. The $134,622.30 contract will be performed in Herndon, Virginia and supports the FDA's Division of Applied Regulatory Science in studying the chronic effects of drugs on cell cultures containing human organ features. Government Scientific Source Inc. is a leading...
This federal contract award, valued at $34,376.60, was issued by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Bioivt, LLC, a for-profit limited liability company based in Westbury, New York. The contract is for the procurement of 27 vials of cryopreserved hepatocytes, which are specialized biological specimens used in scientific research and medical advancement. The contract award is not designated as a set-aside and was competitively awarded. Bioivt,...